Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.04
Delayed Data
As of Feb 12
 +0.08 / +4.08%
Today’s Change
1.68
Today|||52-Week Range
12.88
-30.85%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close1.96
Today’s open1.96
Day’s range1.93 - 2.10
Volume380,626
Average volume (3 months)759,133
Market cap$124.6M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-81.45%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
FLKSFlex Pharma Inc-0.41-5.55%
MNOVMediciNova Inc-0.03-0.71%
DRRXDURECT Corp+0.04+3.96%
NERVMinerva Neuroscience...+0.08+1.74%
Data as of 3:59pm ET, 02/12/2016

Financials

Next reporting dateMarch 14, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

Partner Offers